FFO
RGNX icon

Fortitude Family Office’s Regenxbio RGNX Stock Holding History

Fortitude Family Office’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.07K Sell
408
-138
-25% -$1.4K ﹤0.01% 1816
2026
Q2 		$6.54K Buy
546
+488
+841% +$4.05K ﹤0.01% 957
2026
Q1 		$486 Buy
+58
New +$609 ﹤0.01% 1740

Other funds holding RGNX

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Fortitude Family Office's RGNX Position: Q3 2026 in Review

Fortitude Family Office reduced its Regenxbio (RGNX) stake by 25% in Q3 2026, selling an estimated $1.4K and leaving 408 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Fortitude Family Office first reported a position in RGNX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.54K in Q2 2026. 10 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

  • Fortitude Family Office held 408 shares of Regenxbio worth $3.07K as of Q3 2026.
  • Fortitude Family Office sold 138 Regenxbio shares in Q3 2026, an estimated $1.4K.
  • Regenxbio made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1816 holding.
  • Fortitude Family Office first reported a position in Regenxbio in Q1 2026 and has held it in 3 quarters since.
  • Fortitude Family Office's Regenxbio position peaked at $6.54K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.